RhumbLine Advisers’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-972
| Closed | -$1.22K | – | 4227 |
|
|
2024
Q2 | $1.22K | Hold |
972
| – | – | ﹤0.01% | 4225 |
|
|
2024
Q1 | $1.09K | Hold |
972
| – | – | ﹤0.01% | 4140 |
|
|
2023
Q4 | $1.29K | Hold |
972
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q3 | $1.03K | Hold |
972
| – | – | ﹤0.01% | 4179 |
|
|
2023
Q2 | $1.08K | Buy |
+972
| New | +$1.08K | ﹤0.01% | 4281 |
|
|
2021
Q2 | – | Sell |
-31,417
| Closed | -$300K | – | 3013 |
|
|
2021
Q1 | $300K | Sell |
31,417
-2,070
| -6% | -$19.8K | ﹤0.01% | 2696 |
|
|
2020
Q4 | $311K | Buy |
33,487
+1,309
| +4% | +$12.2K | ﹤0.01% | 2646 |
|
|
2020
Q3 | $437K | Sell |
32,178
-5,035
| -14% | -$68.4K | ﹤0.01% | 2347 |
|
|
2020
Q2 | $720K | Buy |
+37,213
| New | +$720K | ﹤0.01% | 2183 |
|